Login / Signup

Respiratory repercussions of neurological diseases and how best to manage them.

Marie Carmen ValenzaEsther Prados-RománMaria Granados-SantiagoIrene Torres-SanchezLaura Lopez-LopezIrene Cabrera-Martos
Published in: Expert review of respiratory medicine (2019)
Introduction: The high incidence of respiratory impairments in patients with neurological diseases is recognized, but the design, dosage, and effectiveness of interventions to manage them are seen as an ongoing challenge.Areas covered: This article summarizes the evidence regarding the respiratory impairments in major neurological diseases, and how to best manage them.Expert opinion: On the balance of available evidence, respiratory impairments are part of the clinical profile of neurological diseases including Multiple Sclerosis, Stroke, and Parkinson's Disease, acquiring more importance as the pathologies progress. It is recognized that knowledge gaps remain in some areas of relevance related to respiratory function and further research is required. When considering the therapeutic options, the respiratory training emerges as the approach with most evidence. However, important questions remain unsolved: what kind, how much, and how to best include respiratory interventions is uncertain. At present, respiratory programs also fail to include clinically relevant factors such as ambulation and trunk stability.
Keyphrases
  • multiple sclerosis
  • respiratory tract
  • healthcare
  • systematic review
  • public health
  • risk factors
  • cerebral ischemia
  • clinical practice